• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

围产期心肌病:赞比亚卢萨卡一家转诊医院女性患者的特征与结局

Peripartum cardiomyopathy: Characteristics and outcomes among women seen at a referral hospital in Lusaka, Zambia.

作者信息

Strasserking Fiona E, Musho Jane, Heimburger Douglas C, Mutale Wilbroad, Damp Julie A, Mumba Ngosa, Goma Fastone

机构信息

Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Division of Cardiovascular Medicine and Office of Global Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.

出版信息

Int J Cardiol Heart Vasc. 2022 Aug 22;42:101104. doi: 10.1016/j.ijcha.2022.101104. eCollection 2022 Oct.

DOI:10.1016/j.ijcha.2022.101104
PMID:36046756
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9421395/
Abstract

BACKGROUND

Peripartum cardiomyopathy (PPCM) disproportionately affects women of African descent, however knowledge about this disease in African countries is limited.

OBJECTIVES

To describe the phenotype of women with PPCM seen at a referral hospital in Zambia and examine outcomes at 6 months.

METHODS

A prospective observational study describing characteristics and 6-month outcomes was performed at the University Teaching Hospital Echocardiography Lab in Lusaka, Zambia.

RESULTS

We enrolled 45 participants with PPCM and 38 were seen at 6-month follow up; 3 (7 %) died and 4 (9 %) were lost to follow up. Mean age was 32.9 years (SD:7.0); mean BMI was 25.3 kg/m (SD:4.1), mean parity was 3.4 (SD:2.2) children and twin pregnancies occurred in 4 (9 %). Median time from symptom onset to diagnosis was 60 days (IQR: 1-280). 20 (44 %) reported gestational hypertension and 10 (22 %) reported preeclampsia. Baseline median left ventricular ejection fraction (LVEF) was 36 % (IQR: 11-45), median left ventricular end-diastolic volume (LVEDV) was 150 mL (IQR: 58-229) and 79 % described New York Heart Association (NYHA) functional class IV symptoms. Median LVEF after 6 months was 49 % (IQR: 23-68;  < 0.001) and median LVEDV was 121 mL (IQR: 66-200;  < 0.001). At 6-month follow up 45 % had LVEF ≥ 50 %, 42 % had LVEDV ≤ 106 mL and 1 (3 %) had NYHA functional class IV symptoms.

CONCLUSIONS

Hypertension was prevalent in this cohort. Overall mortality rate was low and clinically significant improvements in cardiac parameters were seen in over 40%. Further research is needed to identify and mitigate gaps in diagnosis and management.

摘要

背景

围产期心肌病(PPCM)对非洲裔女性的影响尤为严重,然而非洲国家对这种疾病的了解有限。

目的

描述赞比亚一家转诊医院中患有PPCM的女性的表型,并检查6个月时的结局。

方法

在赞比亚卢萨卡大学教学医院超声心动图实验室进行了一项前瞻性观察性研究,描述其特征和6个月时的结局。

结果

我们纳入了45例PPCM患者,38例在6个月随访时接受检查;3例(7%)死亡,4例(9%)失访。平均年龄为32.9岁(标准差:7.0);平均体重指数为25.3kg/m(标准差:4.1),平均产次为3.4个孩子(标准差:2.2),4例(9%)为双胎妊娠。从症状出现到诊断的中位时间为60天(四分位间距:1-280)。20例(44%)报告有妊娠期高血压,10例(22%)报告有先兆子痫。基线时左心室射血分数(LVEF)中位数为36%(四分位间距:11-45),左心室舒张末期容积(LVEDV)中位数为150mL(四分位间距:58-229),79%的患者描述有纽约心脏协会(NYHA)IV级功能症状。6个月后的LVEF中位数为49%(四分位间距:23-68;P<0.001),LVEDV中位数为121mL(四分位间距:66-200;P<0.001)。在6个月随访时,45%的患者LVEF≥50%,42%的患者LVEDV≤106mL,1例(3%)有NYHA IV级功能症状。

结论

该队列中高血压很常见。总体死亡率较低,超过40%的患者心脏参数有临床显著改善。需要进一步研究以识别和缩小诊断与管理方面的差距。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fd3/9421395/605214563ee7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fd3/9421395/41ccf89bf129/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fd3/9421395/c286ccf1f6bb/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fd3/9421395/605214563ee7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fd3/9421395/41ccf89bf129/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fd3/9421395/c286ccf1f6bb/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fd3/9421395/605214563ee7/gr3.jpg

相似文献

1
Peripartum cardiomyopathy: Characteristics and outcomes among women seen at a referral hospital in Lusaka, Zambia.围产期心肌病:赞比亚卢萨卡一家转诊医院女性患者的特征与结局
Int J Cardiol Heart Vasc. 2022 Aug 22;42:101104. doi: 10.1016/j.ijcha.2022.101104. eCollection 2022 Oct.
2
Long-term outcome of peripartum cardiomyopathy in a population with high seropositivity for human immunodeficiency virus.围生期心肌病在人类免疫缺陷病毒血清学阳性率高的人群中的长期预后。
Int J Cardiol. 2011 Mar 3;147(2):202-8. doi: 10.1016/j.ijcard.2009.08.022. Epub 2009 Sep 13.
3
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry.围生期心肌病患者的临床表现、处理和 6 个月结局:ESC-EORP 注册研究。
Eur Heart J. 2020 Oct 14;41(39):3787-3797. doi: 10.1093/eurheartj/ehaa455.
4
Peripartum cardiomyopathy in Iraq: initial registry-based data and 6 month outcomes.伊拉克围产期心肌病:基于初始登记的资料和 6 个月的结局。
ESC Heart Fail. 2021 Oct;8(5):4048-4054. doi: 10.1002/ehf2.13502. Epub 2021 Jun 28.
5
Long-Term Cardiac Function After Peripartum Cardiomyopathy and Preeclampsia: A Danish Nationwide, Clinical Follow-Up Study Using Maximal Exercise Testing and Cardiac Magnetic Resonance Imaging.围生期心肌病和子痫前期后长期心脏功能:丹麦全国性最大运动试验和心脏磁共振成像临床随访研究。
J Am Heart Assoc. 2018 Oct 16;7(20):e008991. doi: 10.1161/JAHA.118.008991.
6
Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry.围生期心肌病女性患者的高血压病:ESC EORP PPCM 注册研究的新认识。
Eur J Heart Fail. 2021 Dec;23(12):2058-2069. doi: 10.1002/ejhf.2264. Epub 2021 Aug 25.
7
Predictors of outcome in 176 South African patients with peripartum cardiomyopathy.176 例南非围生期心肌病患者结局的预测因素。
Heart. 2013 Mar;99(5):308-13. doi: 10.1136/heartjnl-2012-302760. Epub 2012 Oct 31.
8
Peripartum Cardiomyopathy Characteristics and Outcomes in Canadian Aboriginal and Non-Aboriginal Women.加拿大原住民和非原住民妇女围产期心肌病的特征与结局
Can J Cardiol. 2017 Apr;33(4):471-477. doi: 10.1016/j.cjca.2016.11.001. Epub 2016 Nov 11.
9
Prognostic value of NT-proBNP for myocardial recovery in peripartum cardiomyopathy (PPCM).NT-proBNP 对围产期心肌病 (PPCM) 心肌恢复的预后价值。
Clin Res Cardiol. 2021 Aug;110(8):1259-1269. doi: 10.1007/s00392-021-01808-z. Epub 2021 Feb 8.
10
Risk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillator.围生期心肌病伴严重左心室功能障碍患者发生心室颤动的风险-可穿戴式除颤器的价值。
Eur J Heart Fail. 2014 Dec;16(12):1331-6. doi: 10.1002/ejhf.188. Epub 2014 Nov 5.

引用本文的文献

1
Peripartum cardiomyopathy: a review of prevalence and treatment trends from an African perspective.围产期心肌病:从非洲视角看患病率及治疗趋势综述
Front Cardiovasc Med. 2025 Apr 28;12:1568493. doi: 10.3389/fcvm.2025.1568493. eCollection 2025.
2
Peripartum cardiomyopathy: a comprehensive and contemporary review.围生期心肌病:全面而现代的综述。
Heart Fail Rev. 2024 Nov;29(6):1261-1278. doi: 10.1007/s10741-024-10435-5. Epub 2024 Sep 30.
3
Recent highlights on myocarditis, cardiovascular complications of COVID-19, and cardiomyopathies from the International Journal of Cardiology: Heart & Vasculature.

本文引用的文献

1
Pathophysiology and risk factors of peripartum cardiomyopathy.围生期心肌病的病理生理学和危险因素。
Nat Rev Cardiol. 2022 Aug;19(8):555-565. doi: 10.1038/s41569-021-00664-8. Epub 2022 Jan 11.
2
Peripartum cardiomyopathy: from genetics to management.围生期心肌病:从遗传学角度到治疗管理。
Eur Heart J. 2021 Aug 21;42(32):3094-3102. doi: 10.1093/eurheartj/ehab458.
3
Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy.围生期心肌病的遗传与表型特征。
《国际心脏病学杂志:心脏与血管》关于心肌炎、新冠病毒病的心血管并发症及心肌病的近期要点
Int J Cardiol Heart Vasc. 2022 Dec;43:101154. doi: 10.1016/j.ijcha.2022.101154. Epub 2022 Nov 22.
Circulation. 2021 May 11;143(19):1852-1862. doi: 10.1161/CIRCULATIONAHA.120.052395. Epub 2021 Apr 20.
4
Clinical Features and Outcomes of Peripartum Cardiomyopathy in Nigeria.尼日利亚围生期心肌病的临床特征和结局。
J Am Coll Cardiol. 2020 Nov 17;76(20):2352-2364. doi: 10.1016/j.jacc.2020.09.540.
5
Clinical presentation, management, and 6-month outcomes in women with peripartum cardiomyopathy: an ESC EORP registry.围生期心肌病患者的临床表现、处理和 6 个月结局:ESC-EORP 注册研究。
Eur Heart J. 2020 Oct 14;41(39):3787-3797. doi: 10.1093/eurheartj/ehaa455.
6
Peripartum Cardiomyopathy: JACC State-of-the-Art Review.围生期心肌病:美国心脏病学会临床心脏病学实践中的现状综述。
J Am Coll Cardiol. 2020 Jan 21;75(2):207-221. doi: 10.1016/j.jacc.2019.11.014.
7
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy.围生期心肌病的病理生理学、诊断和治疗:欧洲心脏病学会心力衰竭协会围生期心肌病研究组的立场声明。
Eur J Heart Fail. 2019 Jul;21(7):827-843. doi: 10.1002/ejhf.1493. Epub 2019 Jun 27.
8
The REDCap consortium: Building an international community of software platform partners.REDCap 联盟:构建软件平台合作伙伴的国际社区。
J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.
9
Comparison of Clinical Characteristics and Outcomes of Peripartum Cardiomyopathy Between African American and Non-African American Women.非裔美国女性和非非裔美国女性围产期心肌病的临床特征和结局比较。
JAMA Cardiol. 2017 Nov 1;2(11):1256-1260. doi: 10.1001/jamacardio.2017.3574.
10
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies.围产期心肌病和扩张型心肌病的共同遗传易感性。
N Engl J Med. 2016 Jun 30;374(26):2601-2. doi: 10.1056/NEJMc1602671.